Financial results - YAKYS BIOMED S.R.L.

Financial Summary - Yakys Biomed S.r.l.
Unique identification code: 38549260
Registration number: J15/1569/2017
Nace: 4778
Sales - Ron
94.453
Net Profit - Ron
-9.390
Employees
2
Open Account
Company Yakys Biomed S.r.l. with Fiscal Code 38549260 recorded a turnover of 2024 of 94.453, with a net profit of -9.390 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al altor bunuri noi having the NACE code 4778.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Yakys Biomed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 438 22.630 91.737 102.772 92.513 87.289 94.453
Total Income - EUR - - - 1.312 24.861 98.597 102.774 104.122 92.293 94.512
Total Expenses - EUR - - - 2.462 25.514 94.685 100.732 102.987 90.274 102.048
Gross Profit/Loss - EUR - - - -1.149 -653 3.912 2.042 1.135 2.019 -7.535
Net Profit/Loss - EUR - - - -1.162 -909 3.178 1.415 92 1.136 -9.390
Employees - - - 1 1 1 2 3 3 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 8.8%, from 87.289 euro in the year 2023, to 94.453 euro in 2024. The Net Profit decreased by -1.130 euro, from 1.136 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Yakys Biomed S.r.l.

Rating financiar

Financial Rating -
YAKYS BIOMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Yakys Biomed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Yakys Biomed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Yakys Biomed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Yakys Biomed S.r.l. - CUI 38549260

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 124 122 157 0 0 804 560
Current Assets - - - 4.572 7.191 24.569 17.515 16.716 22.378 14.292
Inventories - - - 4.438 7.059 21.358 16.878 14.912 18.876 12.842
Receivables - - - 0 0 2.720 378 378 164 9
Cash - - - 134 132 491 258 1.426 3.338 1.441
Shareholders Funds - - - -1.119 -2.006 1.210 2.598 2.699 3.827 -5.584
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 5.815 9.319 23.517 14.917 14.016 19.355 20.436
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4778 - 4778"
CAEN Financial Year 4778
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 14.292 euro in 2024 which includes Inventories of 12.842 euro, Receivables of 9 euro and cash availability of 1.441 euro.
The company's Equity was valued at -5.584 euro, while total Liabilities amounted to 20.436 euro. Equity decreased by -9.389 euro, from 3.827 euro in 2023, to -5.584 in 2024.

Risk Reports Prices

Reviews - Yakys Biomed S.r.l.

Comments - Yakys Biomed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.